Researchers from the Wuhan Institute of Virology in China have discovered a new strain of the coronavirus in bats, which ...

A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus ...

Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...

Moderna Inc. rose by as much as 6.6%, while Novavax Inc. climbed 7.8%. American depositary receipts of BioNTech SE, the partner of Pfizer in the development of the Covid vaccine, surged by 5.1%, and ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%.

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...

Novavax (NVAX) ended the recent trading session at $7.92, demonstrating a -1.25% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.43%. At ...

Shares of Novavax Inc. NVAX slipped 1.25% to $7.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.47% to 19,962.